Literature DB >> 18632952

Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector.

J Lucifora1,2, D Durantel3,1,2, L Belloni4,5, L Barraud5, S Villet1,2, I E Vincent1,2, S Margeridon-Thermet1,2, O Hantz1,2, A Kay1,2, M Levrero6,4, F Zoulim3,1,2.   

Abstract

One of the major problems in gaining further insight into hepatitis B virus (HBV)/host-cell interactions is to improve the existing cellular models for the study of HBV replication. The first objective of this study was to improve the system based on transduction of HepG2 cells with a recombinant baculovirus to study HBV replication. A new HBV recombinant baculovirus, Bac-HBV-1.1, in which the synthesis of pre-genomic RNA is driven by a strong mammalian promoter, was generated. Transduction with this new recombinant baculovirus led to higher levels of HBV replication in HepG2 cells compared with levels obtained with previously described baculovirus vectors. The initiation of a complete HBV DNA replication cycle in Bac-HBV-1.1-transduced HepG2 cells was shown by the presence of HBV replicative intermediates, including covalently closed circular DNA (cccDNA). Only low levels of cccDNA were detected in the nucleus of infected cells. Data showed that cccDNA resulted from the recycling of newly synthesized nucleocapsids and was bound to acetylated histones in a chromatin-like structure. HBV particles released into the supernatant of transduced HepG2 cells were infectious in differentiated HepaRG cells. Several Bac-HBV-1.1 baculoviruses containing HBV strains carrying mutations conferring resistance to lamivudine and/or adefovir were constructed. Phenotypic analysis of these mutants confirmed the results obtained with the transfection procedures. In conclusion, an improved cell-culture system was established for the transduction of replication-competent HBV genomes. This will be useful for future studies of the fitness of HBV mutants.

Entities:  

Mesh:

Year:  2008        PMID: 18632952     DOI: 10.1099/vir.0.83659-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

Review 1.  Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?

Authors:  David Durantel
Journal:  Antivir Ther       Date:  2010

2.  Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy.

Authors:  Oliver Schildgen; Cynthia Olotu; Anneke Funk; Bernhard Zöllner; Martin Helm; Jürgen Kurt Rockstroh; Hüseyin Sirma
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

3.  Proteomic analysis of primary duck hepatocytes infected with duck hepatitis B virus.

Authors:  Yanfeng Zhao; Haijing Ben; Su Qu; Xinwen Zhou; Liang Yan; Bin Xu; Shuangcheng Zhou; Qiang Lou; Rong Ye; Tianlun Zhou; Pengyuan Yang; Di Qu
Journal:  Proteome Sci       Date:  2010-06-07       Impact factor: 2.480

4.  Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.

Authors:  Séverine Margeridon; Sandra Carrouée-Durantel; Isabelle Chemin; Luc Barraud; Fabien Zoulim; Christian Trépo; Alan Kay
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

5.  RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.

Authors:  Guanhui Wu; Florentin Pastor; Jiazeng Sun; Naimur Rahman; Wen-Hung Wang; Zhengtao Zhang; Philippe Merle; Lijian Hui; Anna Salvetti; David Durantel; Danzhou Yang; Ourania Andrisani
Journal:  Gut       Date:  2021-05-21       Impact factor: 23.059

6.  Innate antiviral immune responses to hepatitis B virus.

Authors:  Malika Ait-Goughoulte; Julie Lucifora; Fabien Zoulim; David Durantel
Journal:  Viruses       Date:  2010-07-05       Impact factor: 5.818

7.  HBV life cycle: entry and morphogenesis.

Authors:  Stephanie Schädler; Eberhard Hildt
Journal:  Viruses       Date:  2009-09-01       Impact factor: 5.048

8.  Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.

Authors:  Xin Cheng; Weiwei Guan; Shuo Sun; Baosheng Li; Haijun Li; Fubiao Kang; Jiwen Kang; Dongliang Yang; Michael Nassal; Dianxing Sun
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.

Authors:  Xiaoyan Guo; Ping Chen; Xiaohu Hou; Wenjuan Xu; Dan Wang; Tian-Yan Wang; Liping Zhang; Gang Zheng; Zhi-Liang Gao; Cheng-Yi He; Boping Zhou; Zhi-Ying Chen
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 10.  Recent advances in live cell imaging of hepatoma cells.

Authors:  Sandeep Salipalli; Prafull Kumar Singh; Jürgen Borlak
Journal:  BMC Cell Biol       Date:  2014-07-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.